62
Views
0
CrossRef citations to date
0
Altmetric
Response to Letter

“Is Fosfomycin As Effective As Claimed On MDR Gram-Negative Bacteria Causing UTI?” [Response To Letter]

, , , , , ORCID Icon & show all
Pages 3091-3092 | Published online: 03 Oct 2019

References

  • Singh G, Singh BR. Is fosfomycin as effective as claimed on MDR gram-negative bacteria causing UTI? Infect Drug Resist. 2019;12:2711–2712. doi:10.2147/IDR.S22476931564920
  • Banerjee S, Sengupta M, Sarker TK. Fosfomycin susceptibility among multidrug-resistant, extended-spectrum beta-lactamase-producing, carbapenem-resistant uropathogens. Indian J Urol. 2017;33:149–154. doi:10.4103/iju.IJU_285_1628469304
  • Tulara NK. Nitrofurantoin and fosfomycin for extended spectrum beta-lactamases producing escherichia coli and klebsiella pneumoniae. J Global Infect Dis. 2018;10:19–21. doi:10.4103/jgid.jgid_72_17
  • Clinical Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing. CLSI Supplement M100 Twenty-Ninth Edition. Wayne, USA: CLSI; 2019.
  • European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameter, version9.0, valid from 2019-01-01; 2019 Available from: http://www.eucast.org/. Accessed 821, 2019.